Korean J Gastroenterol.  2021 Jan;77(1):1-3. 10.4166/kjg.2021.012.

Therapeutic Approach to Inflammatory Bowel Disease Using Human Microbial Modification

• Na SY

• KMID: 2510769
• DOI: http://doi.org/10.4166/kjg.2021.012

Reference

1. Ng SC, Tang W, Ching JY, et al. 2013; Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology. 145:158–165. e2. DOI: 10.1053/j.gastro.2013.04.007. PMID: 23583432.

2. Liu JZ, van Sommeren S, Huang H, et al. 2015; Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 47:979–986. DOI: 10.1038/ng.3359. PMID: 26192919. PMCID: PMC4881818.

3. Zhang M, Sun K, Wu Y, Yang Y, Tso P, Wu Z. 2017; Interactions between intestinal microbiota and host immune response in inflammatory bowel disease. Front Immunol. 8:942. DOI: 10.3389/fimmu.2017.00942. PMID: 28855901. PMCID: PMC5558048.

4. Knights D, Lassen KG, Xavier RJ. 2013; Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut. 62:1505–1510. DOI: 10.1136/gutjnl-2012-303954. PMID: 24037875. PMCID: PMC3822528.

5. Sepehri S, Khafipour E, Bernstein CN, et al. 2011; Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis. 17:1451–1463. DOI: 10.1002/ibd.21509. PMID: 21674703.

6. Sokol H, Pigneur B, Watterlot L, et al. 2008; Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 105:16731–16736. DOI: 10.1073/pnas.0804812105. PMID: 18936492. PMCID: PMC2575488.

7. Narula N, Kassam Z, Yuan Y, et al. 2017; Systematic review and meta-analysis: fecal microbiota transplantation for treatment of active ulcerative colitis. Inflamm Bowel Dis. 23:1702–1709. DOI: 10.1097/MIB.0000000000001228. PMID: 28906291.

8. Lamb CA, Kennedy NA, Raine T, et al. 2019; British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 68(Suppl 3):s1–s106. DOI: 10.1136/gutjnl-2019-318484. PMID: 31562236. PMCID: PMC6872448.

9. Sood A, Midha V, Makharia GK, et al. 2009; Inflammatory Bowel Disease and Human Microbiome 3 VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol. 7:1202–1209. DOI: 10.1016/j.cgh.2009.07.016. PMID: 19631292.

10. Scaldaferri F, Gerardi V, Mangiola F, et al. 2016; Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update. World J Gastroenterol. 22:5505–5511. DOI: 10.3748/wjg.v22.i24.5505. PMID: 27350728. PMCID: PMC4917610.

11. Kamada N, Maeda K, Inoue N, et al. 2008; Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells. Infect Immun. 76:214–220. DOI: 10.1128/IAI.01193-07. PMID: 17967864. PMCID: PMC2223654.

12. Losurdo G, Iannone A, Contaldo A, Ierardi E, Di Leo A, Principi M. 2015; Escherichia coli Nissle 1917 in ulcerative colitis treatment: systematic review and meta-analysis. J Gastrointestin Liver Dis. 24:499–505. DOI: 10.15403/jgld.2014.1121.244.ecn. PMID: 26697577.

13. Harbord M, Eliakim R, Bettenworth D, et al. 2017; Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management. J Crohns Colitis. 11:769–784. DOI: 10.1093/ecco-jcc/jjx009. PMID: 28513805.

14. Su GL, Ko CW, Bercik P, et al. 2020; AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology. 159:697–705. DOI: 10.1053/j.gastro.2020.05.059. PMID: 32531291.

15. Oh GM, Moon W, Seo KI, et al. 2021; Therapeutic potential of escherichia coli nissle 1917 in clinically remission-attained ulcerative colitis patients: a hospital-based cohort study. Korean J Gastroenterol. 77:12–21. DOI: 10.4166/kjg.2020.0119. PMID: 33361702.